Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
Novax-backed Apoex is heading for a sale
September 23, 2020
According to Realtid's sources, the owners have brought in Carnegie as an advisor to probe the interest among potential buyers and run an auction on fast-growing pharmaceutical distributor Apoex, which has many of Sweden's county councils and regions as customers. Axel Johnson Group's investment company Novax owns 44 pct. of Appoex. Apoex's annual report for 2019 is not available, but the company had sales of SEK 4.6bn in 2018 and Apoex had an EBITDA of SEK 24m. Johan Möller serves as CEO.
ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: